pain relief News
-
VFF Leads Mandatory Pain Relief for Mulesing
The Victorian Farmers Federation (VFF) Livestock Group is leading regulatory change in partnership with the Victorian Government to mandate pain relief for mulesing sheep to achieve the highest animal welfare outcomes. “Mulesing remains the most effective method for controlling breech flystrike, a terribly painful and fatal affliction for sheep. To deliver the best possible animal welfare ...
-
Study Compares Nerivio® to Standard Care Medications for Acute Treatment of Migraine in Adolescents
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a study in Pain Medicine that compared adolescent response to migraine medications to their response to Remote Electrical Neuromodulation (REN) administered by Nerivio®. The study found statistically significant differences in ...
-
Lumosa Recognized as Top 10 Biotech Companies in Taiwan
The Taiwan government has been promoting policies to develop the biotechnology industry since the 1980s. According to the Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs, Taiwan's biotechnology/pharmaceutical industry in is valued at US$20 billion in 2020, a 7.4% growth from 2019, while the revenue of the pharmaceutical sector has reached US$3 billion, a ...
-
Nerivio® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced it has seen consistent growth in the usage of Nerivio, marking more than 100,000 treatments in the USA. "We are at a crossroads for acute migraine treatment, where traditional drug-based solutions are being challenged by FDA-authorized, novel digital ...
-
Bionix Development Co. Appoints Dorian Drake International Inc. as Export Sales Representative
Bionix Development Corporation, a leader in the development, manufacturing and marketing of innovative medical devices and equipment, has appointed Dorian Drake International Inc. as its export sales representative for its Medical Technologies products division in select Latin American and Caribbean markets. Dorian Drake will act as Bionix’s sales and marketing arm in its sales ...
-
Targeting Alternative Opioid Receptor Reduces Drug Side Effects
A new study published in Proceedings of the National Academy of Sciences (PNAS) indicates, “Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles, making them a promising target for treating chronic inammatory pain with fewer side eects.” Researchers used cells from humans and mice with inammatory bowel ...
-
Presidio MedicalTM Announces Publication of ULFTM Neuromodulation Research in Science Translational Medicine
SOUTH SAN FRANCISCO, Calif., August 25, 2021 – Presidio Medical, Inc., a clinical-stage medical technology company developing a transformational neuromodulation platform, today announced research involving the company’s novel ULF™ neuromodulation therapy has been published in Science Translational Medicine. The publication, titled “Neuromodulation using ultra low ...
-
Peer-Reviewed Published Study Provides Further Evidence for the Safety and Efficacy of Nerivio in Patients with Chronic Migraine
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today a new peer-reviewed article, with the publication of a chronic migraine study by Pain Reports. The prospective, multi-center, open-label trial (NCT04194008), evaluated the efficacy and safety of remote electrical neuromodulation (REN) for the acute ...
-
First tahoe unicompartmental knee system (TUKS) procedure
El Dorado Hills, CA, June 2022 – Shalby Advanced Technologies, (DBA Consensus Orthopedics) proudly reports its first implantation of The Tahoe Uni-compartmental Knee System (TUKS), in Plano,Texas on June 2, 2022. The surgery was performed by Dr. Richard Reitman and was a great surgical success. This surgery marks the culmination of over 6 years of research and development. The patient, a 52 ...
-
Saluda Medical Announces Publication of 24-Month Spinal Cord Stimulation Results with the Evoke® System
Results show ~90% overall back and leg responder rate, ~68% high responder rate, and zero explants due to loss of efficacy ~83% of patients reduced or eliminated opioid use Need for patient re-programming visits nearly eliminated after 12 months Represents the first peer reviewed SCS study to show responder and high responder rate improvement over time Saluda Medical Pty Limited ...
-
Panag Pharma announces licensing agreement with Tetra Bio Pharma
Halifax, Nova Scotia. Panag Pharma Inc. announces that it has entered into a licensing agreement with Tetra Bio Pharma for its Topical ARx and Ocular products. The Licensing Agreement provides for the continued development and commercialization of Panag’s unique products focused on providing patients with effective relief from pain. Dr. Cheliak, Panag’s CEO notes that ...
-
FDA Approves Theranica`s Nerivio® for Acute Treatment of Migraine in Adolescents
Theranica, a prescribed digital therapeutics (PDT) company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio® therapeutic device has received the Food and Drug Administration clearance to market for an expanded indication for acute treatment of episodic or chronic migraine in people 12 years and older. The use of the device in the ...
-
Saluda Medical Announces Highlights from 2021 North American Neuromodulation Society (NANS) Meeting
Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of closed-loop spinal cord stimulation for the treatment of chronic pain, announced scientific highlights from the 2021 North American Neuromodulation Society (NANS 2021) Virtual Meeting, including real-world European commercial results and sub-analyses of 24-month and 12-month clinical data from the ...
-
Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain
Transformative closed-loop technology senses the spinal cord’s response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment Long-term results published in two premier clinical journals show clinically meaningful improvements in pain relief, physical and emotional functioning, sleep quality, and health-related quality of life Saluda Medical Pty ...
-
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will be featured as a presenting company at the H.C. Wainwright BioConnect Virtual Conference to be held January 10-13, 2022. Brian Murphy, Chief Executive Officer of NanoVibronix, will provide an ...
By NanoVibronix
-
Differences Between Spinal Blocks & Epidurals
The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. The reason for this difference is that the former is an anesthetic, while the latter is an analgesic—no sensation versus no pain. But pain elimination comes with a total lack of feeling in the lower body, due to ...
-
What to Expect for an Epidural Injection
Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. Many are forced to miss days of work due to injury. With rising healthcare costs, many back pain sufferers think that they are left without a real solution, until they try epidural injections. An epidural injection is the infusion of ...
-
Pushing Forward Through Loss of Leader: EO2 Releases New, Large Dressing for their Oxygen Therapy
EO2 Concepts announced today the release of a new, larger wound dressing for post-surgical dehiscence and large, painful leg ulcers. This new 5x7 OxySpur oxygen diffusion dressing is part of the OxyGeni System which provides a complete oxygen therapy and wound monitoring system. Continuous Diffusion of Oxygen (CDO) therapy provides full closure and pain relief to patients dealing with chronic, ...
By EO2 Concepts
-
Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation
Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced long-term results of its double-blind Level 1 EVOKE randomized controlled trial (RCT) published online in ...
-
Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress
Key data highlights with the Evoke® System to include holistic composite treatment outcomes for disrupting the chronic pain cycle; opioid-sparing effects of therapy; real-world results; and cost-effectiveness compared to open-loop stimulation. Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you